| scholarly article | Q13442814 |
| P356 | DOI | 10.1172/JCI112442 |
| P8608 | Fatcat ID | release_lhinmnhxxzfxpiezhugmvfkthm |
| P953 | full work available at URL | https://www.jci.org/articles/view/112442 |
| P243 | OCLC control number | 115268931 |
| P3181 | OpenCitations bibliographic resource ID | 2605917 |
| P932 | PMC publication ID | 424498 |
| P698 | PubMed publication ID | 3514679 |
| P2093 | author name string | G Starkebaum | |
| J M Harlan | |||
| P2860 | cites work | Homocystinemia. Vascular injury and arterial thrombosis | Q68342307 |
| D-Penicillamine: analysis of the mechanism of copper-catalyzed hydrogen peroxide generation | Q70081325 | ||
| Homocysteine in the plasma of renal transplant recipients: effects of cofactors for methionine metabolism | Q70188404 | ||
| The participation of hydroperoxides and oxygen radicals in the control of prostaglandin synthesis | Q70434451 | ||
| Endothelial cell dysfunction in homocystinuria | Q70455278 | ||
| Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease | Q70690494 | ||
| Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons | Q71097689 | ||
| Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis | Q71236870 | ||
| Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury | Q71282008 | ||
| Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency | Q71662220 | ||
| Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent | Q28248838 | ||
| Sulphur containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide | Q28319264 | ||
| Generation of superoxide free radical during the autoxidation of thiols | Q34204226 | ||
| Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis | Q34207431 | ||
| H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors | Q34478055 | ||
| Presence of lipid hydroperoxide in human plasma | Q34532273 | ||
| Resistance of human tumor cells in vitro to oxidative cytolysis | Q34541025 | ||
| Effect of hydrogen peroxide on prostaglandin production and cellular integrity in cultured porcine aortic endothelial cells | Q34543767 | ||
| Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture | Q34620804 | ||
| Unique efficiency of methionine metabolism in premenopausal women may protect against vascular disease in the reproductive years | Q35208030 | ||
| Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis | Q35904374 | ||
| The detection of cysteine‐homocysteine mixed disulphide in plasma of normal fasting man | Q39623108 | ||
| Bovine superoxide dismutase and copper ions potentiate the bactericidal effect of autoxidizing cysteine | Q40078118 | ||
| The pathogenesis of atherosclerosis (second of two parts) | Q40547842 | ||
| Neutrophil-mediated endothelial injury in vitro mechanisms of cell detachment | Q40684511 | ||
| Glutathione redox cycle protects cultured endothelial cells against lysis by extracellularly generated hydrogen peroxide | Q40925470 | ||
| Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. | Q41576959 | ||
| Production of arteriosclerosis by homocysteinemia | Q42648820 | ||
| Mutagenicity of Glutathione and Cysteine in the Ames Test | Q50211434 | ||
| The reaction of cysteine with ceruloplasmin copper | Q50921936 | ||
| Cysteine—Homocysteine Mixed Disulphide: Differing Plasma Concentrations in Normal Men and Women | Q51661954 | ||
| The copper catalyzed oxidation of cysteine to cystine. | Q54424767 | ||
| The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes | Q60786799 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | copper | Q753 |
| endothelium | Q111140 | ||
| P304 | page(s) | 1370-6 | |
| P577 | publication date | 1986-01-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine | |
| P478 | volume | 77 |
| Q24302132 | A novel homocysteine-responsive gene, smap8, modulates mitogenesis in rat vascular smooth muscle cells |
| Q28068779 | A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus |
| Q35603932 | ADMA and oxidative stress |
| Q85094853 | Acute Liver Failure and Reversible Leukoencephalopthy in a Pediatric Patient With Homocystinuria |
| Q28354189 | Acute hyperhomocysteinaemia affects pulse pressure but not microvascular vasodilator function |
| Q43069827 | Adult rats are more sensitive to the vascular effects induced by hyperhomocysteinemia than young rats |
| Q35824103 | Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen |
| Q77124479 | Age and cystathionine beta-synthase activity in cultured fibroblasts from patients with arterial and venous vascular disease |
| Q44524401 | Alteration in the redox state of plasma in heart-transplant patients with moderate hyperhomocysteinemia |
| Q54088301 | Antioxidants, but not B-group vitamins increase the resistance of low-density lipoprotein to oxidation: a randomized, factorial design, placebo-controlled trial. |
| Q42714111 | Arterial endothelial barrier dysfunction: actions of homocysteine and the hypoxanthine-xanthine oxidase free radical generating system |
| Q41486934 | Assessment of a possible link between hyperhomocysteinemia and hyperuricemia |
| Q58180355 | Association between elevated plasma total homocysteine and increased common carotid artery wall thickness |
| Q38194052 | Association of MTHFR C677T polymorphism and risk of cerebrovascular disease in Chinese population: an updated meta-analysis |
| Q41099743 | Associations between Homocysteine, Folic Acid, Vitamin B12 and Alzheimer's Disease: Insights from Meta-Analyses |
| Q44460931 | Atherosclerosis and uremia: signifance of non-traditional risk factors |
| Q36647334 | Atherosclerotic vascular disease: will folate or gene therapy be useful? |
| Q48944746 | Beneficial effects of folic acid on enhancement of memory and antioxidant status in aged rat brain. |
| Q40693454 | Bioactivation of thiols by one-electron oxidation |
| Q34107196 | Biochemical evidence for a link between elevated levels of homocysteine and lipid peroxidation in vivo |
| Q44945420 | Biphasic effect of hydrogen peroxide on skeletal muscle arteriolar tone via activation of endothelial and smooth muscle signaling pathways |
| Q34107404 | Blood levels of homocysteine and atherosclerotic vascular disease |
| Q44487554 | Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria |
| Q37434251 | Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients? |
| Q44407404 | Changes in markers of vascular injury in response to transient hyperhomocysteinemia |
| Q54097159 | Characterization of the adduct formed from the reaction between homocysteine thiolactone and low-density lipoprotein: antioxidant implications. |
| Q42159238 | Characterization of the stress-inducing effects of homocysteine |
| Q56832765 | Circulating cell adhesion molecules and endothelial markers before and after transluminal angioplasty in peripheral arterial occlusive disease |
| Q42068706 | Converging evidence of mitochondrial dysfunction in a yeast model of homocysteine metabolism imbalance |
| Q44426592 | Copper induces type II nitric oxide synthase in vivo |
| Q89009865 | Copper transporters and copper chaperones: roles in cardiovascular physiology and disease |
| Q40737536 | Copper-induced vascular endothelial growth factor expression and wound healing |
| Q35037752 | Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage. |
| Q73189643 | Correlation of homocytsteine levels with the extent of coronary atherosclerosis in patients with low cardiovascular risk profiles |
| Q92186536 | Cu/Zn-superoxide dismutase and wild-type like fALS SOD1 mutants produce cytotoxic quantities of H2O2 via cysteine-dependent redox short-circuit |
| Q41208237 | Cyclin A transcriptional suppression is the major mechanism mediating homocysteine-induced endothelial cell growth inhibition |
| Q42400895 | Cystathionine beta synthase modulates senescence of human endothelial cells. |
| Q44426855 | DNA damage by ethylbenzenehydroperoxide formed from carcinogenic ethylbenzene by sunlight irradiation |
| Q37352044 | Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis |
| Q42577216 | Defective responses to oxidative stress in protein l-isoaspartyl repair-deficient Caenorhabditis elegans |
| Q55064708 | Detection and investigation of the molecular nature of low-molecular-mass copper ions in isolated rheumatoid knee-joint synovial fluid. |
| Q31967263 | Differences between cysteine and homocysteine in the induction of deoxyribose degradation and DNA damage |
| Q45903164 | Differential expression of lipid peroxidation and total antioxidant status in Indian patients with cardiovascular and cerebrovascular disease. |
| Q46802337 | Distribution of androstenedione and its effects on total free fatty acids in pregnant rats |
| Q44373903 | Effect of a methionine-supplemented diet on the blood pressure of Wistar-Kyoto and spontaneously hypertensive rats |
| Q33834502 | Effect of folic Acid on hematological changes in methionine-induced hyperhomocysteinemia in rats |
| Q74649129 | Effect of homocysteine and cholesterol in raising plasma homocysteine, cholesterol and triglyceride levels |
| Q42520120 | Effect of homocysteine on arachidonic acid release in human platelets |
| Q42514335 | Effect of homocysteine on nitric oxide production in coronary microvascular endothelial cells |
| Q41961021 | Effect of prolonged incubation with copper on endothelium-dependent relaxation in rat isolated aorta. |
| Q73310526 | Effect of short-term vitamin (folic acid, vitamins B6 and B12) administration on endothelial dysfunction induced by post-methionine load hyperhomocysteinemia |
| Q43687601 | Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine |
| Q45743581 | Effects of DL-homocysteine thiolactone on cardiac contractility, coronary flow, and oxidative stress markers in the isolated rat heart: the role of different gasotransmitters. |
| Q44264664 | Effects of certain micronutrients and melatonin on plasma lipid, lipid peroxidation, and homocysteine levels in rats. |
| Q46973576 | Effects of estrogen and estrogen-progestogen therapy on homocysteine levels and their correlation with carotid vascular resistance |
| Q40931043 | Effects of folate deficiency on embryonic development |
| Q54325558 | Effects of folic acid on the development and oxidative stress of mouse embryos exposed to heat stress. |
| Q73289615 | Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface |
| Q44457155 | Effects of long-term administration of methionine on vascular endothelium in rabbits |
| Q40028542 | Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension. |
| Q44474830 | Effects of vitamin supplementation and hyperhomocysteinemia on atherosclerosis in apoE-deficient mice |
| Q39317514 | Elevated serum homocysteine level as an independent risk factor for erectile dysfunction: a prospective pilot case-control study |
| Q35055199 | Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia |
| Q28591362 | Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia |
| Q45135207 | Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA. |
| Q90150796 | Evaluation of homocystein and asymmetric dimethyl arginine levels in patients with coronary slow flow phenomenon |
| Q31941042 | Evidence against oxidative stress as mechanism of endothelial dysfunction in methionine loading model. |
| Q40513939 | Evidence for a protective (synergistic?) effect of B-vitamins and omega-3 fatty acids on cardiovascular diseases |
| Q63197184 | Experimental evidence of oxidative stress in plasma of homocystinuric patients: A possible role for homocysteine |
| Q43784576 | Folate deficiency-induced oxidative stress and apoptosis are mediated via homocysteine-dependent overproduction of hydrogen peroxide and enhanced activation of NF-kappaB in human Hep G2 cells |
| Q36351455 | Folates in Plants: Research Advances and Progress in Crop Biofortification |
| Q51559556 | Folic acid improves arterial endothelial function in adults with hyperhomocystinemia. |
| Q35675495 | Folic acid supplementation reduces oxidative stress and hepatic toxicity in rats treated chronically with ethanol |
| Q58402090 | Folic acid, pyridoxine, cobalamin, and homocysteine and their relationship to cardiovascular disease in end-stage renal disease |
| Q33622289 | Fracture is additionally attributed to hyperhomocysteinemia in men and premenopausal women with type 2 diabetes |
| Q34722600 | Free radicals, diabetes and endothelial dysfunction. |
| Q42391435 | Genes, greens, and homocysteine |
| Q36265315 | Genetic determinants of hyperhomocysteinemia in atherosclerosis |
| Q74342695 | High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders |
| Q72049325 | Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease |
| Q51760865 | Homocysteine Increases Tau Phosphorylation, Truncation and Oligomerization. |
| Q53793755 | Homocysteine accelerates endothelial cell senescence. |
| Q42523086 | Homocysteine activates platelets in vitro |
| Q35582716 | Homocysteine and Essential Hypertension |
| Q35027762 | Homocysteine and arterial disease. Experimental mechanisms |
| Q34455031 | Homocysteine and cardiovascular disease in diabetes mellitus |
| Q34641564 | Homocysteine and cardiovascular disease: current evidence and future prospects |
| Q44485364 | Homocysteine and hemostatic disorder as a risk factor for myocardial infarction at a young age. |
| Q38948319 | Homocysteine and hydrogen sulfide in epigenetic, metabolic and microbiota related renovascular hypertension |
| Q37271062 | Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism |
| Q47731955 | Homocysteine and oxidative modification of plasma proteins. |
| Q58297326 | Homocysteine and total antioxidant status in acute myocardial infarction patients among Tamil population |
| Q40911244 | Homocysteine and vascular dysfunction. |
| Q33969606 | Homocysteine as a risk factor for development of microalbuminuria in type 2 diabetes |
| Q43739303 | Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes. |
| Q43812254 | Homocysteine attenuates endothelial haem oxygenase-1 induction by nitric oxide (NO) and hypoxia |
| Q24337464 | Homocysteine contribution to DNA damage in cystathionine β-synthase-deficient patients |
| Q40707186 | Homocysteine decreases endothelin-1 expression by interfering with the AP-1 signaling pathway |
| Q40941876 | Homocysteine decreases endothelin-1 production by cultured human endothelial cells. |
| Q74339183 | Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity |
| Q42238968 | Homocysteine in dogs with systemic inflammatory response syndrome. |
| Q38223130 | Homocysteine in renovascular complications: hydrogen sulfide is a modulator and plausible anaerobic ATP generator |
| Q43912991 | Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells |
| Q42339328 | Homocysteine inhibits adipogenesis in 3T3-L1 preadipocytes |
| Q43713584 | Homocysteine inhibits tumor necrosis factor-induced activation of endothelium via modulation of nuclear factor-kappa b activity |
| Q39255149 | Homocysteine is linked to macular edema in type 2 diabetes |
| Q44123489 | Homocysteine is the only plasma thiol associated with carotid artery remodeling |
| Q46770313 | Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population |
| Q44533433 | Homocysteine oxidation and apoptosis: a potential cause of cleft palate |
| Q32134706 | Homocysteine potentiates copper- and amyloid beta peptide-mediated toxicity in primary neuronal cultures: possible risk factors in the Alzheimer's-type neurodegenerative pathways |
| Q35538219 | Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc. |
| Q44219160 | Homocysteine promotes the LDL oxidase activity of ceruloplasmin |
| Q73385445 | Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide |
| Q40839063 | Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C. |
| Q28367240 | Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals |
| Q34066620 | Homocysteine to hydrogen sulfide or hypertension |
| Q33855736 | Homocysteine toxicity in Escherichia coli is caused by a perturbation of branched-chain amino acid biosynthesis |
| Q37126086 | Homocysteine toxicity in connective tissue: theories, old and new. |
| Q34352230 | Homocysteine, Another Risk Factor for Alzheimer Disease, Impairs Apolipoprotein E3 Function |
| Q37231486 | Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk |
| Q40304955 | Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells |
| Q39288512 | Homocysteine, an additional factor, is linked to osteoporosis in postmenopausal women with type 2 diabetes |
| Q41508423 | Homocysteine, oxidative stress, and vascular disease |
| Q41763764 | Homocysteine- and cysteine-mediated growth defect is not associated with induction of oxidative stress response genes in yeast. |
| Q40996776 | Homocysteine-dependent alterations in mitochondrial gene expression, function and structure. Homocysteine and H2O2 act synergistically to enhance mitochondrial damage |
| Q44497496 | Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition. |
| Q28365886 | Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways |
| Q38293097 | Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes |
| Q35612116 | Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor |
| Q33732664 | Homocysteine. |
| Q36410590 | Homocysteine: role and implications in atherosclerosis |
| Q38460537 | Homocysteinemia as a risk factor for atherosclerosis: a review |
| Q36680974 | Homocystinuria: what about mild hyperhomocysteinaemia? |
| Q35594829 | Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion |
| Q43978616 | Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study |
| Q44049645 | Hyperhomocyst(e)inemia induces accelerated transplant vascular sclerosis in syngeneic and allogeneic rat cardiac transplants |
| Q35008507 | Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease. |
| Q34435609 | Hyperhomocysteinaemia and associated disease |
| Q74578253 | Hyperhomocysteinaemia and vascular disease |
| Q46663117 | Hyperhomocysteinaemia induced by dietary folate restriction causes kidney oxidative stress in rats |
| Q50995714 | Hyperhomocysteinaemia is a risk factor for vein graft stenosis. |
| Q36669874 | Hyperhomocysteinaemia; with reference to its neuroradiological aspects |
| Q36740468 | Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation. |
| Q35209853 | Hyperhomocysteinemia and its role in the development of atherosclerosis |
| Q57811732 | Hyperhomocysteinemia and the response to vitamin supplementation |
| Q37812131 | Hyperhomocysteinemia and thrombophilia |
| Q77621762 | Hyperhomocysteinemia and thrombosis |
| Q33797998 | Hyperhomocysteinemia as a Metabolic Risk Factor for Glucose Intolerance Among High-Risk Groups of Chinese Adults |
| Q73627437 | Hyperhomocysteinemia following oral methionine load is associated with increased lipid peroxidation |
| Q44887004 | Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy |
| Q43297450 | Hyperhomocysteinemia induced by feeding rats diets rich in DL-homocysteine thiolactone promotes alterations on carotid reactivity independent of arterial structure. |
| Q34222836 | Identification and characterization of two isoenzymes of methionine gamma-lyase from Entamoeba histolytica: a key enzyme of sulfur-amino acid degradation in an anaerobic parasitic protist that lacks forward and reverse trans-sulfuration pathways |
| Q34249956 | Impaired homocysteine metabolism and atherothrombotic disease |
| Q35542924 | Implications of Oxidative Stress and Homocysteine in the Pathophysiology of Essential Hypertension |
| Q77370130 | Improvement of coronary artery disease in a patient with hyperhomocysteinemia: report of a case |
| Q53834913 | Increased Plasma Homocysteine Level is Associated with Executive Dysfunction in Type 2 Diabetic Patients with Mild Cognitive Impairment. |
| Q42197124 | Increased hepatic lipid peroxidation with methionine toxicity in the rat. |
| Q71699966 | Increased lipid peroxidation and antioxidant activity in methionine-induced hepatitis in rabbits |
| Q87957224 | Influence of hyperhomocysteinemia on left ventricular diastolic function in Chinese patients with hypertension |
| Q35600441 | Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction |
| Q34213851 | Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine |
| Q37724635 | Integration of ER stress, oxidative stress and the inflammatory response in health and disease |
| Q35600437 | Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium |
| Q24188051 | Interventions for lowering plasma homocysteine levels in kidney transplant recipients |
| Q43833278 | Intraperitoneal infusion of homocysteine increases intimal hyperplasia in balloon-injured rat carotid arteries |
| Q41951247 | Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta |
| Q43839970 | Is homocysteine a pro-oxidant? |
| Q43907969 | Leukocytes extravasation in acute homocysteinemic rats |
| Q67560177 | Lipid peroxidation in homocysteinaemia |
| Q51548088 | Lipid peroxidation induced in vivo by hyperhomocysteinaemia in pigs. |
| Q33790567 | MAT1A variants are associated with hypertension, stroke, and markers of DNA damage and are modulated by plasma vitamin B-6 and folate |
| Q46772983 | MTHFR C677T polymorphism associates with unexplained infertile male factors |
| Q36133409 | MTHFR C677T polymorphism is associated with hyperlipidemia in women with polycystic ovary syndrome |
| Q46949321 | MTHFR C677T polymorphism, GSTM1 deletion and male infertility: a possible suggestion of a gene-gene interaction? |
| Q42137731 | Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability |
| Q80821757 | Mechanism of UVA-dependent DNA damage induced by an antitumor drug dacarbazine in relation to its photogenotoxicity |
| Q39599160 | Mechanism of constrictive vascular remodeling by homocysteine: role of PPAR. |
| Q39957446 | Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells |
| Q41281849 | Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937) |
| Q46495530 | Methionine, folic acid and vitamin B12 in growing-finishing pigs: impact on growth performance and meat quality |
| Q54361317 | Methylenetetrahydrofolate reductase C677T polymorphism is not associated with male infertility in a South Indian population. |
| Q28506932 | Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia |
| Q44413402 | Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism. |
| Q25257578 | Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies |
| Q33819518 | Moderate hyperhomocysteinemia and cardiovascular disease |
| Q37274442 | Molecular mechanisms of adaptation to folate deficiency |
| Q50940035 | Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. |
| Q40923118 | New approaches to the prevention of atherosclerosis |
| Q41701273 | New risk factors for coronary heart disease in Asia |
| Q40113992 | No evidence for prooxidative effects of homocysteine in vascular endothelial cells |
| Q40693186 | Nutrition, endothelial cell metabolism, and atherosclerosis |
| Q34006724 | Nutritional aspects and possible pathological mechanisms of hyperhomocysteinaemia: an independent risk factor for vascular disease. |
| Q34086042 | Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms |
| Q41679390 | Oral administration of homocysteine leads to increased plasma triglycerides and homocysteic acid — additional mechanisms in homocysteine induced endothelial damage? |
| Q33947823 | Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction |
| Q44281727 | Peroxisome proliferator ameliorates endothelial dysfunction in a murine model of hyperhomocysteinemia |
| Q44133768 | Peroxisome proliferators compete and ameliorate Hcy-mediated endocardial endothelial cell activation |
| Q37299480 | Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy |
| Q64260769 | Plasma Free Homocysteine Levels in Children with Idiopathic Nephrotic Syndrome |
| Q46415528 | Plasma homocysteine and total thiol content in patients with exudative age-related macular degeneration |
| Q54969525 | Plasma homocysteine is associated with increased oxidative stress and antioxidant enzyme activity in welders. |
| Q36449909 | Plasma homocysteine level and its genotypes as a risk factor for coronary artery disease in patients undergoing coronary angiography |
| Q37356525 | Predictive role of C677T MTHFR polymorphism in variable efficacy of photodynamic therapy for neovascular age-related macular degeneration. |
| Q44913163 | Predictive value of plasma asymmetric dimethylarginine, homocysteine, and high-sensitive CRP levels in occult coronary artery disease: A multidetector-row computed tomography study |
| Q34645884 | Prenatal infectious and nutritional factors and risk of adult schizophrenia |
| Q42007616 | Protective effect of hydrogen sulfide on balloon injury-induced neointima hyperplasia in rat carotid arteries |
| Q41054019 | Protein binding of homocysteine and other thiols in HeLa cell cultures after addition of homocysteine and copper ions |
| Q31834254 | Protein tyrosine phosphatase-dependent proteolysis of focal adhesion complexes in endothelial cell apoptosis |
| Q41521475 | Putative mechanisms for vascular damage by homocysteine |
| Q54366789 | Quantitative proteomic profiling of the Escherichia coli response to metallic copper surfaces. |
| Q37828680 | Reactive oxygen species as mediators of signal transduction in cardiovascular disease |
| Q44628122 | Red wine prevents homocysteine-induced endothelial dysfunction in porcine coronary arteries |
| Q44355803 | Reduction in plasma total homocysteine through increasing folate intake in healthy individuals is not associated with changes in measures of antioxidant activity or oxidant damage |
| Q21146652 | Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis |
| Q43761093 | Relative roles of albumin and ceruloplasmin in the formation of homocystine, homocysteine-cysteine-mixed disulfide, and cystine in circulation |
| Q44683752 | Restenosis in Intervened Coronaries with Hyperhomocysteinemia (RICH). |
| Q37276483 | Risk factors for coronary artery sclerosis in patients with diabetes. |
| Q35831223 | Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. |
| Q35090352 | Role of nitric oxide in matrix remodeling in diabetes and heart failure |
| Q40460088 | S-Nitrosothiols and the Bioregulatory Actions of Nitrogen Oxides Through Reactions with Thiol Groups |
| Q44019190 | S-adenosylhomocysteine, but not homocysteine, is toxic to yeast lacking cystathionine beta-synthase |
| Q39741317 | Salidroside improves homocysteine-induced endothelial dysfunction by reducing oxidative stress |
| Q50192080 | Selenoproteins and cardiovascular stress |
| Q50859058 | Serum folate and risk for coronary heart disease: results from a cohort of US adults. |
| Q84790241 | Stereospecific in vitro embryotoxicity of l-homocysteine in pre- and post-implantation rodent embryos |
| Q73556126 | Stimulation of endothelial nitric oxide production by homocyst(e)ine |
| Q44578841 | Stimulatory effect of homocysteine on interleukin-8 expression in human endothelial cells |
| Q73209033 | Stroke prevention |
| Q48427488 | Sudden death of an 18-year-old man with homocystinuria and intracranial inflammatory pseudotumor (IPT). |
| Q92008457 | Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia? |
| Q44221895 | Sustained increases of plasma homocysteine, copper, and serum ceruloplasmin after coronary artery bypass grafting |
| Q30927502 | TDAG51 Is Induced by Homocysteine, Promotes Detachment-mediated Programmed Cell Death, and Contributes to the Development of Atherosclerosis in Hyperhomocysteinemia |
| Q90420713 | The Impact of Uremic Toxins on Cerebrovascular and Cognitive Disorders |
| Q89553066 | The Link between Homocysteine and Omega-3 Polyunsaturated Fatty Acid: Critical Appraisal and Future Directions |
| Q90494329 | The association between homocysteine and ischemic stroke subtypes in Chinese: A meta-analysis |
| Q46484349 | The association of endothelin-1 with markers of oxidative stress in a biethnic South African cohort: the SABPA study |
| Q41083459 | The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress |
| Q78115598 | The effect of cyst(e)ine on the auto-oxidation of homocysteine |
| Q24800878 | The effect on endothelial function of vitamin C during methionine induced hyperhomocysteinaemia |
| Q89220460 | The effects of L-cysteine and N-acetyl-L-cysteine on homocysteine metabolism and haemostatic markers, and on cardiac and aortic histology in subchronically methionine-treated Wistar male rats |
| Q41103765 | The effects of homocysteine and copper ions on the concentration and redox status of thiols in cell line cultures |
| Q44615958 | The effects of hydrogen peroxide promoted by homocysteine and inherited catalase deficiency on human hypocatalasemic patients |
| Q28349035 | The effects of oral methionine and homocysteine on endothelial function |
| Q41486362 | The effects of oral vitamin supplementation on cardiovascular risk factors |
| Q68015552 | The prevalence of homocysteinemia and hypercholesterolemia in angiographically defined coronary heart disease |
| Q43687631 | The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis |
| Q37351584 | The relation of markers of inflammation and endothelial dysfunction to the prevalence and progression of diabetic retinopathy: Wisconsin epidemiologic study of diabetic retinopathy |
| Q41099877 | The role of free radicals as mediators of endothelial cell injury in hyperhomocysteinemia |
| Q43792229 | Thiol oxidase activity of copper, zinc superoxide dismutase |
| Q33785883 | Total homocysteine and cardiovascular disease |
| Q44041076 | Upregulation of smooth muscle cell collagen production by homocysteine-insight into the pathogenesis of homocystinuria |
| Q34395823 | Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease |
| Q37356860 | Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia |
| Q44014722 | Vascular endothelial dysfunction associated with elevated serum homocysteine levels in rat adjuvant arthritis: effect of vitamin E administration |
| Q55110135 | Vegetarian Diet and Cardiometabolic Risk among Asian Indians in the United States. |
| Q52937866 | Vein graft disease in a knockout mouse model of hyperhomocysteinaemia. |
| Q43734672 | Vitamin C prevents radiation-induced endothelium-dependent vasomotor dysfunction and de-endothelialization by inhibiting oxidative damage in the rat. |
| Q42843095 | Vitamin E supplementation in chemical colorectal carcinogenesis: a two-edged knife |
| Q46809067 | Waist-to-hip ratio correlates with homocysteine levels in male patients with coronary artery disease |
| Q74243285 | [Congenital errors of metabolism: cause of oxidative stress?] |
Search more.